BIOLOGY.DIGITAL

UPDATE News

Gain Therapeutics Secures FDA IND Clearance for AI-Designed GT-02287

Gain Therapeutics, a clinical-stage biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has authorized its Investigational New Drug (IND) application for GT-02287. This c

Aidoc's AI for Radiology Reports Gets FDA Breakthrough Designation

Aidoc has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its "First Read" AI system. This AI tool analyzes chest radiographs and generates preliminary radiology r

10x Genomics Q1 Beat & AI Drug Discovery Positioning

10x Genomics reported Q1 results surpassing revenue and earnings estimates, with strong uptake of new single-cell and spatial consumables like FLEX Apex and Atara. The company is positioning its expan

MedSyntra Bolsters Healthcare AI Vision with New Board Appointment

MedSyntra, a company at the intersection of healthcare, AI, and sovereign medical data infrastructure, announced the appointment of Dr. George Syrmalis to its Board of Directors. This move strengthens

Sanofi Invests $294M to Expand Toronto AI Center of Excellence

Sanofi is making a significant investment of $294 million to expand its global Artificial Intelligence (AI) Centre of Excellence in Toronto. This initiative, supported by a conditional grant from the

AI Aids Pancreatic Cancer Detection, New Drug Fast-Tracked by FDA

Fox News reported on two significant advancements offering new hope in the fight against pancreatic cancer. The FDA has fast-tracked daraxonrasib, an investigational drug by Revolution Medicines, whic

CorTec BCI System Enables Stroke Patient to Control Computer with Mind

CorTec GmbH announced that the first participant in a clinical trial successfully controlled a computer through thought alone using their Brain Interchange™ BCI system. This fully implanted, wireless

Intellia Files for FDA Approval of CRISPR Gene-Editing Therapy

Intellia Therapeutics has filed for FDA approval of its CRISPR-based medicine, lonvo-z, following positive preliminary Phase 3 clinical trial data. The therapy demonstrated a significant reduction in

Neuralink Targets High-Volume Brain Implant Production by 2026

Elon Musk's neurotechnology company, Neuralink, is planning to scale up production of its brain-computer interface (BCI) devices. The company aims for high-volume manufacturing and fully automated sur

OpenEvidence Reaches 1M Daily AI Clinical Consultations

OpenEvidence has achieved a historic milestone of one million clinical consultations between NPI-verified physicians and its AI system within a single 24-hour period on March 10, 2026. This accomplish

3billion Showcases AI-Powered Variant Interpretation Platform GEBRA

3billion, a leader in AI-powered rare disease diagnostics, is showcasing its proprietary SaaS-based variant interpretation platform, GEBRA, at the 2026 American College of Medical Genetics and Genomic

How Lilly Used AI To Crank Up Production Of Its Popular GLP-1s

Eli Lilly has successfully utilized AI, specifically digital twin technology, to optimize the manufacturing process of its popular GLP-1 drugs, Zepbound and Mounjaro. This AI-driven approach significa

Recursion's AI Drug Discovery Platform Achieves Clinical & Sanofi Milestones

Recursion Pharmaceuticals has reported its first positive clinical proof-of-concept for REC-4881 in familial adenomatous polyposis, demonstrating tangible results from its AI-driven drug discovery app

MindRank Doses First Patient in Phase III AI-Designed GLP-1RA Trial

MindRank, an AI-driven drug discovery company, has dosed the first patient in its Phase III clinical trial for MDR-001, an AI-designed oral GLP-1 receptor agonist for obesity and type 2 diabetes in Ch

Recursion Makes the Unknown Known in Rare Disease Drug Discovery

Dr. Najat Khan, the new CEO of Recursion, is steering the company's focus towards demonstrating clinical outcomes in AI-driven drug discovery. This shift is underscored by recent positive data from th